ImmunityBio, Inc. (IBRX)
7.575
-0.22
(-2.76%)
USD |
NASDAQ |
Aug 24, 16:00
7.52
-0.06
(-0.73%)
After-Hours: 19:54
ImmunityBio Price to Book Value
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| March 30, 2021 | 22.00 |
| March 29, 2021 | 22.84 |
| March 26, 2021 | 24.80 |
| March 25, 2021 | 28.61 |
| March 24, 2021 | 27.26 |
| March 23, 2021 | 31.87 |
| March 22, 2021 | 35.29 |
| March 19, 2021 | 32.91 |
| March 18, 2021 | 31.82 |
| March 17, 2021 | 33.30 |
| March 16, 2021 | 29.98 |
| March 15, 2021 | 28.54 |
| March 12, 2021 | 28.29 |
| March 11, 2021 | 31.52 |
| March 10, 2021 | 35.84 |
| March 09, 2021 | 30.09 |
| March 08, 2021 | 26.19 |
| March 05, 2021 | 24.82 |
| March 04, 2021 | 23.85 |
| March 03, 2021 | 24.62 |
| March 02, 2021 | 26.27 |
| March 01, 2021 | 30.84 |
| February 26, 2021 | 30.11 |
| February 25, 2021 | 31.66 |
| February 24, 2021 | 30.24 |
| Date | Value |
|---|---|
| February 23, 2021 | 29.99 |
| February 22, 2021 | 39.13 |
| February 19, 2021 | 36.23 |
| February 18, 2021 | 34.22 |
| February 17, 2021 | 31.30 |
| February 16, 2021 | 31.01 |
| February 12, 2021 | 28.64 |
| February 11, 2021 | 24.12 |
| February 10, 2021 | 24.35 |
| February 09, 2021 | 25.99 |
| February 08, 2021 | 24.82 |
| February 05, 2021 | 21.97 |
| February 04, 2021 | 19.86 |
| February 03, 2021 | 19.27 |
| February 02, 2021 | 19.35 |
| February 01, 2021 | 18.69 |
| January 29, 2021 | 17.48 |
| January 28, 2021 | 17.21 |
| January 27, 2021 | 18.30 |
| January 26, 2021 | 17.73 |
| January 25, 2021 | 17.61 |
| January 22, 2021 | 15.98 |
| January 21, 2021 | 15.75 |
| January 20, 2021 | 16.07 |
| January 19, 2021 | 16.99 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Sarepta Therapeutics, Inc. | 1.253 |
| Cogent Biosciences, Inc. | 13.30 |
| Moderna, Inc. | 8.192 |
| Arrowhead Pharmaceuticals, Inc. | 26.30 |
| Oncolytics Biotech, Inc. | -- |
Price to Book Value Related Metrics
| PS Ratio | 45.84 |
| PEG Ratio | -0.0809 |
| Price | 7.575 |
| Earnings Yield | -12.79% |
| Market Cap | 7.978B |
| PEGY Ratio | -0.0809 |